Literature DB >> 8936588

Eukaryotic expression systems: a comparison.

S Geisse1, H Gram, B Kleuser, H P Kocher.   

Abstract

Eukaryotic expression systems are frequently employed for the production of recombinant proteins as therapeutics as well as research tools. Most commonly used expression systems are based on stably transfected adherent CHO cells or nonadherent lymphoid cell lines. An efficient alternative is the infection of insect cells by recombinant baculoviruses. Transient expression in mammalian cells, e.g., COS cells, is often used for the production of smaller quantities of proteins. The choice of a suitable expression system depends largely on the biochemical and biological properties of the protein of interest, as well as on the nature of the planned experiments and the amount of recombinant protein required. We summarize here the expression of the cytokine human Leukemia Inhibitory Factor (hu-LIF) in five of the most commonly used systems, namely in CHO, Sp2/0, MEL, COS, and insect cells, in conjunction with an outline of the principles and characteristics of each of these expression systems. In result, the stably transfected cell lines, CHO, Sp2/0, and MEL cells, gave rise to production of fully glycosylated hu-LIF at variable product titers; incompletely glycosylated, albeit biological action hu-LIF could be rapidly produced by transient expression in COS cells or by baculovirus-mediated infection of insect cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8936588     DOI: 10.1006/prep.1996.0101

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  13 in total

1.  Expression of human proteins at the Southeast Collaboratory for Structural Genomics.

Authors:  Michael R Mayer; Tamara A Dailey; Clay M Baucom; Jill L Supernak; Michael C Grady; Harris E Hawk; Harry A Dailey
Journal:  J Struct Funct Genomics       Date:  2004

2.  Establishment of stable high expression cell line with green fluorescent protein and resistance genes.

Authors:  Shengtao Zhang; Wenli Liu; Peigen He; Feili Gong; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

3.  Two-color selection for amplified co-production of proteins in mammalian cells.

Authors:  Zahra Assur; Ira Schieren; Wayne A Hendrickson; Filippo Mancia
Journal:  Protein Expr Purif       Date:  2007-05-16       Impact factor: 1.650

Review 4.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

5.  Tools for coproducing multiple proteins in mammalian cells.

Authors:  Zahra Assur; Wayne A Hendrickson; Filippo Mancia
Journal:  Methods Mol Biol       Date:  2012

6.  The multifaceted benefits of protein co-expression in Escherichia coli.

Authors:  Alessandra Stefan; Alessandro Ceccarelli; Emanuele Conte; Alejandro Montón Silva; Alejandro Hochkoeppler
Journal:  J Vis Exp       Date:  2015-02-05       Impact factor: 1.355

Review 7.  Gene expression in Mammalian cells and its applications.

Authors:  Kishwar Hayat Khan
Journal:  Adv Pharm Bull       Date:  2013-08-20

8.  Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expression.

Authors:  Michael A Hanson; Alexei Brooun; Kent A Baker; Veli-Pekka Jaakola; Chris Roth; Ellen Y T Chien; Alexander Alexandrov; Jeffrey Velasquez; Leila Davis; Mark Griffith; Kin Moy; Barbie K Ganser-Pornillos; Yuanzi Hua; Peter Kuhn; Sam Ellis; Mark Yeager; Raymond C Stevens
Journal:  Protein Expr Purif       Date:  2007-06-27       Impact factor: 1.650

9.  HaloTag, a Platform Technology for Protein Analysis.

Authors:  Marjeta Urh; Martin Rosenberg
Journal:  Curr Chem Genomics       Date:  2012-12-05

10.  Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents.

Authors:  Mahdi Shabani; Sheyda Hemmati; Reza Hadavi; Zahra Amirghofran; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.